249 related articles for article (PubMed ID: 24727584)
1. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.
Egger C; Gérard C; Vidotto N; Accart N; Cannet C; Dunbar A; Tigani B; Piaia A; Jarai G; Jarman E; Schmid HA; Beckmann N
Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(12):L1064-77. PubMed ID: 24727584
[TBL] [Abstract][Full Text] [Related]
2. Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology.
Egger C; Cannet C; Gérard C; Jarman E; Jarai G; Feige A; Suply T; Micard A; Dunbar A; Tigani B; Beckmann N
PLoS One; 2013; 8(5):e63432. PubMed ID: 23667616
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronidase modulates bleomycin-induced lung injury detected noninvasively in small rodents by radial proton MRI.
Egger C; Cannet C; Gérard C; Dunbar A; Tigani B; Beckmann N
J Magn Reson Imaging; 2015 Mar; 41(3):755-64. PubMed ID: 24623374
[TBL] [Abstract][Full Text] [Related]
4. Activation of somatostatin receptors attenuates pulmonary fibrosis.
Borie R; Fabre A; Prost F; Marchal-Somme J; Lebtahi R; Marchand-Adam S; Aubier M; Soler P; Crestani B
Thorax; 2008 Mar; 63(3):251-8. PubMed ID: 17951277
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin attenuates bleomycin-induced pulmonary fibrosis in rats and the expression of metalloproteinase-9 and tissue inhibitors of metalloproteinase-1 in lung tissue.
Jin X; Dai H; Ding K; Xu X; Pang B; Wang C
Chin Med J (Engl); 2014; 127(7):1304-9. PubMed ID: 24709185
[TBL] [Abstract][Full Text] [Related]
7. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix.
Liu Y; Qi Y
Int Immunopharmacol; 2020 Oct; 87():106774. PubMed ID: 32731178
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats.
Yang D; Yuan W; Lv C; Li N; Liu T; Wang L; Sun Y; Qiu X; Fu Q
Int J Clin Exp Pathol; 2015; 8(2):1270-81. PubMed ID: 25973011
[TBL] [Abstract][Full Text] [Related]
9. Sinapic acid ameliorates bleomycin-induced lung fibrosis in rats.
Raish M; Ahmad A; Ahmad Ansari M; Ahad A; Al-Jenoobi FI; Al-Mohizea AM; Khan A; Ali N
Biomed Pharmacother; 2018 Dec; 108():224-231. PubMed ID: 30219680
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
Kurotsu S; Tanaka K; Niino T; Asano T; Sugizaki T; Azuma A; Suzuki H; Mizushima T
J Pharmacol Exp Ther; 2014 Jul; 350(1):79-88. PubMed ID: 24769542
[TBL] [Abstract][Full Text] [Related]
12. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
13. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ
Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
[TBL] [Abstract][Full Text] [Related]
16. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture.
Chen X; Sun R; Hu J; Mo Z; Yang Z; Liao D; Zhong N
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):278-86. PubMed ID: 18684219
[TBL] [Abstract][Full Text] [Related]
18. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis.
Divya T; Dineshbabu V; Soumyakrishnan S; Sureshkumar A; Sudhandiran G
Chem Biol Interact; 2016 Feb; 246():52-62. PubMed ID: 26768587
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal free-breathing MRI measurement of murine lung physiology in a progressive model of lung fibrosis.
Guo J; Hardie WD; Cleveland ZI; Davidson C; Xu X; Madala SK; Woods JC
J Appl Physiol (1985); 2019 Apr; 126(4):1138-1149. PubMed ID: 30730810
[TBL] [Abstract][Full Text] [Related]
20. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
